A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing ...

A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...

A popular diabetes drug can provide protection against skin cancers, a new study says.Metformin significantly reduces ...

An Oregon cancer patient was “awake and conscious” when his face caught on fire during surgery — leaving him permanently ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...

Although life-saving, immunosuppressive medications tend to elevate the risk of developing certain skin cancers dramatically ...

Shares of Phio Pharmaceuticals Corp. surged 330% Monday afternoon, reaching their highest levels in nearly eight months, to ...

Phio Pharmaceuticals reports promising Phase 1b trial results for PH-762, showing complete tumor clearance in two patients ...

Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, ...